Victrex (LON:VCT) Insider Ian Melling Acquires 3,500 Shares

Victrex plc (LON:VCT) insider Ian Melling acquired 3,500 shares of the firm’s stock in a transaction on Wednesday, December 17th. The shares were bought at an average cost of GBX 643 per share, for a total transaction of £22,505.

Ian Melling also recently made the following trade(s):

• On Wednesday, December 17th, Ian Melling sold 2,546 shares of Victrex stock. The stock was sold at an average price of GBX 646, for a total value of £16,447.16.

Victrex Price Performance

Shares of LON VCT traded up GBX 6 during midday trading on Wednesday, reaching GBX 651. 354,334 shares of the company traded hands, compared to its average volume of 449,884. The stock’s 50-day simple moving average is GBX 640.26 and its 200-day simple moving average is GBX 696.72. The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39. Victrex plc has a 12 month low of GBX 581 and a 12 month high of GBX 1,138. The firm has a market cap of £566.71 million, a PE ratio of 20.47, a PEG ratio of 1.92 and a beta of 0.69.

Victrex (LON:VCT) last released its quarterly earnings results on Tuesday, December 2nd. The company reported GBX 43.90 earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. As a group, equities analysts anticipate that Victrex plc will post 73.1078905 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft lowered their price target on Victrex from GBX 850 to GBX 780 and set a “hold” rating for the company in a report on Tuesday, December 2nd. Four equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Victrex has an average rating of “Hold” and an average price target of GBX 804.50.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.